• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.60% Nasdaq Up 0.23%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    2.33 Down 0.11(4.51%) 2:27PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.44
    Open:2.47
    Bid:2.34 x 400
    Ask:2.35 x 500
    1y Target Est:6.50
    Beta:1.95
    Next Earnings Date:N/A
    Day's Range:2.33 - 2.48
    52wk Range:1.56 - 5.00
    Volume:523,197
    Avg Vol (3m):569,336
    Market Cap:204.56M
    P/E (ttm):N/A
    EPS (ttm):-0.98
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RIGLDown 4.51%204.56M
    AMGNDown 2.86%125.74B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):37.25
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.04
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback